Grown Rogue International (GRUSF) Other Working Capital Changes (2016)
Grown Rogue International's (GRUSF) quarterly Other Working Capital Changes came in at $13438.4 in Q4 2016.
Grown Rogue International (GRUSF) Other Working Capital Changes (2016) Analysis & Trends
Grown Rogue International's Other Working Capital Changes history runs 1 years deep, the most recent figure standing at $13438.4 for Q4 2016.
- On a quarterly basis, Other Working Capital Changes fell 102.11% year-over-year to -$30494.0 in Q4 2019; TTM through Oct 2019 was $1.5 million, a 2.1% decrease from a year earlier, with the FY2019 full-year figure at $511214.0, down 77.29% from the prior year.
- Other Working Capital Changes declined to -$30494.0 in Q4 2019 per GRUSF's latest filing, from $1.4 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.4 million in Q4 2018 and bottomed at -$30494.0 in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2016 | 13,438.39 |
| Nov 30, 2016 | 13,438.39 |
| Nov 30, 2016 | 13,438.39 |